Global Apixaban Market Analysis

Amol

posted on 3 years ago — updated on 1 second ago

328
views

Apixaban Market

The rising prevalence of venous thromboembolism-related disorders is predicted to drive the apixaban market forward. According to the International Society on Thrombosis and Haemostasis 2014 statistics, around 10 million cases of venous thromboembolism occur each year throughout poor, middle, and high income nations. Furthermore, expanding therapeutic indications for apixaban are likely to drive apixaban market expansion. For example, the United States Food and Drug Administration authorised Eliquis in 2014 for the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for lowering the risk of recurrent PE and DVT after initial therapy.

https://knackersblogger.blogspot.com/2022/10/apixaban-market-size-share-outlook-and.html

Amol

Working in Coherent Market Insights. Coherent Market Insights is a global market intelligence and consulting organization, focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan.